Scientists, including one of Indian origin, have developed a new wearable device that can help manage diabetes by monitoring the patient's sweat, an advance that may spell the end for painful needle jabs. The wearable diagnostic biosensor can detect three interconnected compounds - cortisol, glucose and interleukin-6 - in sweat for up to a week without loss of signal integrity. "Type 2 diabetes affects so many people.
If you have to manage and regulate this chronic problem, these markers are the levers that will help you do that," said professor at The University of Texas at Dallas in the US. "We believe we've created the first diagnostic wearable that can monitor these compounds for up to a week, which goes beyond the type of single use monitors that are on the market today," she said. "If a person has chronic stress, their cortisol levels increase, and their resulting insulin…
